10x Genomics Ownership | Who Owns 10x Genomics?

Overview Forecast RevenueFinancials Chart Transcripts

10x Genomics Ownership Summary

10x Genomics is owned by 88.24% institutional investors, 2.17% insiders, and 9.59% retail investors. Fmr is the largest institutional shareholder, holding 10.90% of TXG shares. ARK Innovation ETF is the top mutual fund, with 6.80% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	10x Genomics	88.24%	2.17%	9.59%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Healthcare Information Services Stocks	50.45%	8.11%	41.44%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	13.01M	10.90%	$253.05M
Vanguard group	10.19M	8.53%	$198.18M
Ark investment management	9.31M	7.80%	$181.15M
Blackrock	6.39M	5.35%	$124.34M
Nikko asset management americas	6.15M	5.15%	$119.34M
Sumitomo mitsui trust	6.14M	5.15%	$119.48M
Morgan stanley	5.77M	4.84%	$112.30M
Price t rowe associates inc /md/	2.87M	2.41%	$55.90M
Baillie gifford	2.74M	2.30%	$53.33M
Brown capital management	2.48M	2.08%	$48.31M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Venrock management vi	2.11M	100.00%	$40.98M
Sands capital ventures	481.77K	3.14%	$9.37M
Ark investment management	9.31M	1.61%	$181.15M
Nikko asset management americas	6.15M	1.38%	$119.34M
Soleus capital management	719.00K	1.23%	$13.98M
Brown capital management	2.48M	0.98%	$48.31M
Birchview capital, lp	30.00K	0.54%	$583.50K
Pdt partners	261.88K	0.48%	$5.09M
Granite investment partners	461.01K	0.37%	$8.97M
Slow capital	105.53K	0.33%	$2.05M

Top Buyers

Holder	Shares	% Assets	Change
Ark investment management	9.31M	1.61%	3.03M
Nikko asset management americas	6.15M	1.38%	2.53M
Sumitomo mitsui trust	6.14M	0.09%	2.52M
Ubs asset management americas	1.93M	0.01%	1.79M
Vanguard group	10.19M	0.00%	1.09M

Top Sellers

Holder	Shares	% Assets	Change
Baillie gifford	2.74M	0.04%	-4.68M
Generation investment management llp	-	-	-2.88M
Rtw investments, lp	502.86K	0.15%	-1.05M
Sands capital management	2.33M	0.13%	-1.05M
Price t rowe associates inc /md/	2.87M	0.01%	-783.27K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	991.05K	0.00%	991.05K	$19.28M
Soleus capital management	719.00K	1.23%	719.00K	$13.98M
Deerfield management company, l.p. (series c)	597.00K	0.19%	597.00K	$11.61M
Mirae asset global etfs	141.71K	0.01%	141.71K	$2.76M
Hsbc	91.33K	0.00%	91.33K	$1.80M

Sold Out

Holder	Change
Mather group, llc.	-4.00
Northwest investment counselors	-6.00
Princeton global asset management	-9.00
Rakuten securities	-10.00
Lifesteps financial	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	262	-10.58%	105,357,369	2.80%	88	1.20%	145	-14.71%	75	-
Mar 31, 2024	293	5.40%	102,484,018	6.88%	85	1.31%	170	9.68%	75	-9.64%
Dec 31, 2023	278	5.70%	95,888,619	5.44%	80	1.36%	155	37.17%	83	-17.00%
Sep 30, 2023	263	-5.05%	90,941,886	2.12%	77	1.33%	113	-22.07%	100	26.58%
Jun 30, 2023	277	8.20%	89,057,785	-0.60%	76	1.27%	145	14.17%	79	1.28%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Innovation ETF	8.23M	6.80%	-
ARK Disruptive Innovation Full Composite	7.43M	6.17%	893.39K
Nikko AM ARK Disruptive Innovation A USD	3.64M	3.01%	-68.06K
Vanguard Total Stock Mkt Idx Inv	3.24M	2.67%	-8.69K
ARK Genomic Revolution ETF	2.85M	2.35%	13.71K
Vanguard Small Cap Index	2.53M	2.09%	4.95K
ARK Genomic Revolution	2.52M	2.09%	393.34K
Nikko AM ARK Pstv Chg Innovt P JPY Acc	2.42M	2.00%	-41.69K
Fidelity Select Medical Tech and Devcs	2.20M	1.82%	198.94K
Fidelity Growth Company Fund	2.14M	1.77%	-467.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 22, 2024	Saxonov Serge	Chief Executive Officer	Sell	$152.05K
Aug 22, 2024	Hindson Benjamin J.	See Remarks	Sell	$98.03K
Aug 22, 2024	McAnear Justin J.	Former Chief Financial Officer	Sell	$66.71K
May 22, 2024	McAnear Justin J.	Chief Financial Officer	Sell	$71.36K
May 22, 2024	Saxonov Serge	Chief Executive Officer	Sell	$118.53K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	3
2024 Q1	-	9
2023 Q4	-	11
2023 Q3	-	14

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 88.24%, followed by 2.17% insiders and 9.59% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 50.45%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Fmr (13.01M shares, 10.90%), Vanguard group (10.19M shares, 8.53%), and Ark investment management (9.31M shares, 7.80%). Together, they hold 27.23% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Innovation ETF is the top mutual fund holder of 10x Genomics shares, with 6.80% of its total shares outstanding invested in 8.23M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools